Sonoma Pharmaceuticals Correlations

SNOA Stock

USD 2.27 0.07 3.18%

The current 90-days correlation between Sonoma Pharmaceuticals and China Pharma Holdings is 0.08 (i.e., Significant diversification). The correlation of Sonoma Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Sonoma Pharmaceuticals Correlation With Market

Significant diversification

The correlation between Sonoma Pharmaceuticals and DJI is 0.08 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Sonoma Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonoma Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For information on how to trade Sonoma Stock refer to our How to Trade Sonoma Stock guide.

Moving together with Sonoma Stock

0.65	EXAS	EXACT Sciences	Pair Corr
0.79	ILMN	Illumina Sell-off Trend	Pair Corr
0.75	ABOS	Acumen Pharmaceuticals	Pair Corr
0.65	ADTX	Aditxt Inc	Pair Corr
0.68	STRO	Sutro Biopharma	Pair Corr
0.68	TCRX	Tscan Therapeutics	Pair Corr
0.64	TERN	Terns Pharmaceuticals	Pair Corr

Moving against Sonoma Stock

0.53	FENC	Fennec Pharmaceuticals	Pair Corr
0.41	OPT	Opthea	Pair Corr
0.33	PFE	Pfizer Inc	Pair Corr
0.32	GANX	Gain Therapeutics	Pair Corr
0.52	PHGE	Biomx Inc	Pair Corr
0.47	DBVT	DBV Technologies Earnings Call This Week	Pair Corr
0.34	BEAM	Beam Therapeutics	Pair Corr

Related Correlations Analysis

	CPHI	UPC	ACOR	AKAN	PTPI	SBFM	GHSI	TKNO	LOVFF	MSMY
CPHI		-0.25	0.0	0.42	-0.06	0.0	0.0	0.18	0.34	0.25	CPHI
UPC	-0.25		0.0	-0.21	0.29	0.34	0.0	-0.27	-0.61	-0.23	UPC
ACOR	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	ACOR
AKAN	0.42	-0.21	0.0		-0.36	-0.04	0.0	0.01	0.55	0.36	AKAN
PTPI	-0.06	0.29	0.0	-0.36		0.69	0.0	0.43	-0.74	-0.66	PTPI
SBFM	0.0	0.34	0.0	-0.04	0.69		0.0	0.32	-0.59	-0.46	SBFM
GHSI	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	GHSI
TKNO	0.18	-0.27	0.0	0.01	0.43	0.32	0.0		-0.01	-0.39	TKNO
LOVFF	0.34	-0.61	0.0	0.55	-0.74	-0.59	0.0	-0.01		0.59	LOVFF
MSMY	0.25	-0.23	0.0	0.36	-0.66	-0.46	0.0	-0.39	0.59		MSMY
	CPHI	UPC	ACOR	AKAN	PTPI	SBFM	GHSI	TKNO	LOVFF	MSMY

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

SBFM	+ 0.69	PTPI
MSMY	+ 0.59	LOVFF
LOVFF	+ 0.55	AKAN
TKNO	+ 0.43	PTPI
AKAN	+ 0.42	CPHI
MSMY	+ 0.36	AKAN

High negative correlations

LOVFF	- 0.74	PTPI
MSMY	- 0.66	PTPI
LOVFF	- 0.61	UPC
LOVFF	- 0.59	SBFM
MSMY	- 0.46	SBFM
MSMY	- 0.39	TKNO

Risk-Adjusted Indicators

There is a big difference between Sonoma Stock performing well and Sonoma Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sonoma Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CPHI	6.05	0.38	0.05	(0.18)	6.67	(9.52)	19.05	(14.29)	45.32
UPC	11.53	(1.24)	0.00	0.23	0.00	0.00	9.52	(24.30)	282.15
ACOR	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
AKAN	3.86	0.50	0.10	0.34	4.52	(4.46)	8.57	(8.98)	25.81
PTPI	8.09	(0.59)	0.00	0.06	0.00	0.00	16.00	(18.18)	136.91
SBFM	3.96	0.28	0.06	0.39	4.89	(4.63)	8.75	(10.00)	39.04
GHSI	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
TKNO	3.91	(0.02)	0.00	(0.04)	0.00	0.00	9.71	(7.18)	21.36
LOVFF	3.89	1.36	0.27	3.75	2.48	(7.76)	15.69	(5.56)	30.02
MSMY	8.79	1.64	0.07	(0.60)	9.56	(33.94)	28.57	(22.22)	124.44

Sonoma Pharmaceuticals Corporate Management

Jerome Dvonch	Interim Officer	Profile
John Poggetto	Controller	Profile
Jerome CPA	Chief Officer	Profile
Victoria Covel	Assistant Controller	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC